These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18704951)

  • 21. Structural basis of conformational transitions in the active site and 80's loop in the FK506-binding protein FKBP12.
    Mustafi SM; Brecher M; Zhang J; Li H; Lemaster DM; Hernández G
    Biochem J; 2014 Mar; 458(3):525-36. PubMed ID: 24405377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the N-terminal domain of human FKBP52.
    Li P; Ding Y; Wu B; Shu C; Shen B; Rao Z
    Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):16-22. PubMed ID: 12499534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-affinity properties of a high-affinity ligand of FKBP12 studied by molecular simulations of a binding intermediate.
    Olivieri L; Gardebien F
    PLoS One; 2014; 9(12):e114610. PubMed ID: 25502559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor rigidity and ligand mobility in trypsin-ligand complexes.
    Guvench O; Price DJ; Brooks CL
    Proteins; 2005 Feb; 58(2):407-17. PubMed ID: 15578663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrocyclic FKBP51 Ligands Define a Transient Binding Mode with Enhanced Selectivity.
    Voll AM; Meyners C; Taubert MC; Bajaj T; Heymann T; Merz S; Charalampidou A; Kolos J; Purder PL; Geiger TM; Wessig P; Gassen NC; Bracher A; Hausch F
    Angew Chem Int Ed Engl; 2021 Jun; 60(24):13257-13263. PubMed ID: 33843131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
    Ianiri G; Applen Clancey S; Lee SC; Heitman J
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials.
    Wang J; Deng Y; Roux B
    Biophys J; 2006 Oct; 91(8):2798-814. PubMed ID: 16844742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structures of Pathogenic Fungal FKBP12s Reveal Possible Self-Catalysis Function.
    Tonthat NK; Juvvadi PR; Zhang H; Lee SC; Venters R; Spicer L; Steinbach WJ; Heitman J; Schumacher MA
    mBio; 2016 Apr; 7(2):e00492-16. PubMed ID: 27118592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraligand hydrophobic interactions rationalize drug affinities for peptidyl-prolyl cis-trans isomerase protein.
    Bizzarri M; Marsili S; Procacci P
    J Phys Chem B; 2011 May; 115(19):6193-201. PubMed ID: 21500789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.
    Liang J; Choi J; Clardy J
    Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):736-44. PubMed ID: 10089303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-terminal region of FKBP12 is essential for binding to the skeletal ryanodine receptor.
    Lee EH; Rho SH; Kwon SJ; Eom SH; Allen PD; Kim DH
    J Biol Chem; 2004 Jun; 279(25):26481-8. PubMed ID: 15033987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysing the visible conformational substates of the FK506-binding protein FKBP12.
    Mustafi SM; Chen H; Li H; Lemaster DM; Hernández G
    Biochem J; 2013 Aug; 453(3):371-80. PubMed ID: 23688288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.
    Wen H; Kang S; Song Y; Song Y; Yang HJ; Kim MH; Park S
    Arch Biochem Biophys; 2012 Jan; 517(1):37-42. PubMed ID: 22100703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. II. Dissociation free energies in drug-receptor systems via nonequilibrium alchemical simulations: application to the FK506-related immunophilin ligands.
    Nerattini F; Chelli R; Procacci P
    Phys Chem Chem Phys; 2016 Jun; 18(22):15005-18. PubMed ID: 27193181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidyl-prolyl isomerase activity of FK506 binding protein 12 prevents tau peptide from aggregating.
    Ikura T; Ito N
    Protein Eng Des Sel; 2013 Sep; 26(9):539-46. PubMed ID: 23832849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution crystal structures of distal histidine mutants of sperm whale myoglobin.
    Quillin ML; Arduini RM; Olson JS; Phillips GN
    J Mol Biol; 1993 Nov; 234(1):140-55. PubMed ID: 8230194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloud computing approaches for prediction of ligand binding poses and pathways.
    Lawrenz M; Shukla D; Pande VS
    Sci Rep; 2015 Jan; 5():7918. PubMed ID: 25608737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallization and preliminary X-ray diffraction analysis of FKBP12 complexed with a novel neurotrophic ligand.
    Li P; Wang L; Ding Y; Wu B; Shu C; Nie A; Li S; Shen B; Rao Z
    Protein Pept Lett; 2002 Oct; 9(5):459-63. PubMed ID: 12370035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 12 kDa FK506-binding protein, FKBP12, modulates the Ca(2+)-flux properties of the type-3 ryanodine receptor.
    Van Acker K; Bultynck G; Rossi D; Sorrentino V; Boens N; Missiaen L; De Smedt H; Parys JB; Callewaert G
    J Cell Sci; 2004 Mar; 117(Pt 7):1129-37. PubMed ID: 14970260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.